# Febuxostat Versus Allopurinol or Placebo in Patients With Hyperuricosuria and Calcium Oxalate Stones

> **NCT01077284** · PHASE2 · COMPLETED · sponsor: **Takeda** · enrollment: 99 (actual)

## Conditions studied

- Hyperuricosuria
- Kidney Stones

## Interventions

- **DRUG:** Febuxostat
- **DRUG:** Allopurinol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01077284
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 99 (ACTUAL)
- **Last updated:** 2013-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01077284

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01077284, "Febuxostat Versus Allopurinol or Placebo in Patients With Hyperuricosuria and Calcium Oxalate Stones". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01077284. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*